Navigation Links
Alcoholism Drug Fails To Prevent Drinking Relapses

The Food and Drug Administration approved naltrexone for the treatment of alcoholism in 1994. At that time, the only other drug therapy available was disulfiram, or Antabuse, which provokes a sickening reaction to alcohol.// A new study casts sobering doubts on earlier claims that an alcoholism drug can truly treat the addiction.

The government is sponsoring a large trial comparing naltrexone, which is also used to treat heroin addiction, with another alcoholism drug, acamprosate. Both medications act on the brain's opioid receptors to make drinking less pleasurable.

Earlier studies, including the work that led to its FDA approval, showed that when combined with counseling naltrexone could help control alcoholism by reducing drinking days and increasing days without liquor. The drug was also shown to suppress cravings and prevent relapses. In fact, the latest study was intended to learn not whether the drug was effective, which was assumed, but for how long. The study says naltrexone fails to prevent drinking relapses, and in fact is no better than sugar pills at keeping hardened alcoholics on the wagon.
'"/>




Page: 1

Related medicine news :

1. Alcoholism Influenced By Both Genetics & Family Environment
2. Detrimental Effect Of Chronic Alcoholism On Male Fertility
3. Smoking And Its Relation To Neurocognitive Deficits In Alcoholism
4. Alcoholism Linked To Higher Death Rates Among Older Men
5. Alcoholism Drug Vivitrol Approved By FDA
6. Is Alcoholism Genetic?
7. Alcoholism & Dependence Seen More Commonly In Early Alcohol Drinkers
8. Study to Identify People at Risk of Alcoholism
9. Mother’s Drinking May Increase Childs Alcoholism Ris
10. Good drinkers have Higher Risk of Alcoholism
11. Effective Cure for Alcoholism – A single dose of LS

Post Your Comments:
(Date:11/21/2009)...isions of Legislation, Continues Push for Progress...ov. 21 With the U.S. ...rdable Health Care for America Act (H.R. 3962), an...forward, Congress has taken decisive steps to fix ...RP hosted an educational forum to discuss the prov...
(Date:11/21/2009)...l apparel company launches men,s lab coats at Medi...Clemente, Calif. (PRWEB) November 21, 2009 -- Mede...today announced the launch of its men,s lab coats,...ternational trade fair for the medical industry he...s men,s collection with three varying lab coat sty...
(Date:11/21/2009)...Group merges their practice with that of E. Steven... (PRWEB) November 21, 2009 -- The New Hav...ibson, Dr. Dean Cloutier, Dr. John Plachtyna and D...practice with that of esteemed colleague Dr. E. St...ed to retire from dentistry in order to concentrat...
(Date:11/20/2009)...ire-FirstCall/ - NUCRYST Pharmaceuticals Corp. ann...s will be held on Monday, December 21, 2009. The p...wo special resolutions. The first special resoluti...substantially all of the assets of NUCRYST, substa...chase agreement dated November 10, 2009 among the ...
(Date:11/20/2009)...re/ -- Following a recall by Unilever The Stop &am...d,s Country Crock ® Side Dishes DELUXE Chedda...ide Dishes DELUXE Four Cheese Pasta due to an unde... dates and UPCs are affected: ,, Shedd,s Count...i Rice 21 oz, UPC 027400218316, Best By NOV 29 09 ...
Breaking Medicine News(10 mins):Health News:AARP Hosts Rep. Bill Foster In Health Care Reform Forum 2Health News:Medelita Introduces Men's Lab Coat Collection 2Health News:Medelita Introduces Men's Lab Coat Collection 3Health News:New Haven Dental Group Expands Their Vision 2Health News:NUCRYST Announces Special Meeting of Shareholders 2Health News:NUCRYST Announces Special Meeting of Shareholders 3Health News:Stop & Shop Alerts Customers to Voluntary Recall by Unilever 2
... facility on Sand Canyon Avenue , ...- Hoag Memorial Hospital Presbyterian has reached ...tate Investment Trust headquartered in Long Beach,...Tenet Healthcare Corporation (NYSE: THC) as Irvine...
... today announced a revised date to report its 2008.... ev3 will now report its 2008 second quarter,and ... 2008, after regular,market trading hours., The c...w its second quarter operating results and future,...
... Experience it at http://SutterHealth.org/an... an e-patient?,Studies show that 80 percent of Ame...ion. Thanks to Web 2.0, e-patients now have even m...alreport ,and you,ll see one of the ways Sutter He...
...ent-resistant, study shows , , THURSDAY, J...e evidence that a new AIDS drug brings significant...ents. , The drug, known as raltegravir (Isentress)...y 24 issue of the New England Journal of Medicine...
...lth and,safety services company, today announced t...les to Living Abroad.com and its multi-national em...-filled online guides to trusted,medical care in h...e assigned abroad on topics such as health service...
...Frank,Ervolino, ND, investigated a product that cl...isks associated with stimulants. He reports that,A...tural product from Zurich,Pharmaceuticals, makes n...DC estimates that greater than 30% of adults are o...
Other Medicine News:Health News:Hoag Hospital Announces Agreement to Open Irvine Campus 2Health News:ev3 Inc. Announces Revised Date for 2008 Second Quarter Financial Results and Conference Call 2Health News:Internet Video Revolution - Sutter Health Harnesses Power of Web 2.0 to Inform Customers 2Health News:Internet Video Revolution - Sutter Health Harnesses Power of Web 2.0 to Inform Customers 3Health News:Internet Video Revolution - Sutter Health Harnesses Power of Web 2.0 to Inform Customers 4Health News:Drug Holds Promise Against AIDS 2Health News:HTH Worldwide to Provide International Health Guide to Living Abroad.com 2Health News:New Natural Product from Zurich Pharmaceuticals Downs Appetite 2
(Date:11/20/2009)... Smith & Nephew ( SNN...ounce the signing of a technology development cont...that may lead to the creation of a fracture fixati...of the limbs of soldiers who sustain battlefield i...earch Projects Agency (DARPA), the central researc...
(Date:11/19/2009)... Warner Chilcott plc (Nasdaq: WCRX...nnounced secondary offering of 20,000,000 of its o...per share. The selling shareholders include funds...nt Banking, J.P. Morgan Partners (advised by CCMP ... other institutional investors and members of the ...
(Date:11/19/2009)...Newswire/ -- In response to an ever-increasing num...dicines, Operation Pangea II, involving 24 countri...th Organization,s International Medical Products A... the dangers of buying medicines online. ,, The...of arrests and the seizure of thousands of potenti...
Breaking Medicine Technology:Smith & Nephew Orthopaedics Selected to Develop New Technology for Treating Battlefield Injuries 2Smith & Nephew Orthopaedics Selected to Develop New Technology for Treating Battlefield Injuries 3Smith & Nephew Orthopaedics Selected to Develop New Technology for Treating Battlefield Injuries 4Warner Chilcott Prices Secondary Equity Offering 2Warner Chilcott Prices Secondary Equity Offering 3Warner Chilcott Prices Secondary Equity Offering 4International Operation Combats Online Supply of Counterfeit and Illegal Medicines 2VIA Pharmaceuticals DGAT1 Inhibitors Featured in American Diabetes Association Poster Presentation 12469 1VIA Pharmaceuticals DGAT1 Inhibitors Featured in American Diabetes Association Poster Presentation 12469 2VIA Pharmaceuticals DGAT1 Inhibitors Featured in American Diabetes Association Poster Presentation 12469 3VIA Pharmaceuticals DGAT1 Inhibitors Featured in American Diabetes Association Poster Presentation 12469 4Health Care Finance to Implement Districts First Medicaid Patient Data Hub Using MedPlus Technology 47898 1Health Care Finance to Implement Districts First Medicaid Patient Data Hub Using MedPlus Technology 47898 2Health Care Finance to Implement Districts First Medicaid Patient Data Hub Using MedPlus Technology 47898 3Health Care Finance to Implement Districts First Medicaid Patient Data Hub Using MedPlus Technology 47898 41st Class Kids Host Miniature Golf Tournament to Raise Money in Support of Continued Obesity Research 47893 1
...e SNS-595 to Next Stage of Phase 2 Trial Achieved,...OR RELEASE AT 3:30 P.M. EDT, TODAY/ -- Sunesis Pha...age biopharmaceutical company developing novel,ant...liminary results from,the first stage of the compa...oduct candidate, SNS-595, in platinum-resistant ov...
...WASHINGTON, Oct. 23 Boston,Scientific Corporation...,results from its CABERNET and BEACH carotid arter...the effectiveness of stenting with embolic,protect...ectomy (CEA), the,surgical treatment for carotid a...esults were presented by L. Nelson Hopkins, M.D., ...
Other Medicine Technology:Sunesis Pharmaceuticals Reports Preliminary SNS-595 Activity in Ovarian Cancer Clinical Trial at AACR-NCI-EORTC International Conference 2Sunesis Pharmaceuticals Reports Preliminary SNS-595 Activity in Ovarian Cancer Clinical Trial at AACR-NCI-EORTC International Conference 3Sunesis Pharmaceuticals Reports Preliminary SNS-595 Activity in Ovarian Cancer Clinical Trial at AACR-NCI-EORTC International Conference 4Sunesis Pharmaceuticals Reports Preliminary SNS-595 Activity in Ovarian Cancer Clinical Trial at AACR-NCI-EORTC International Conference 5Boston Scientific Carotid Artery Stenting Trials Produce Positive Three-Year Results 2Boston Scientific Carotid Artery Stenting Trials Produce Positive Three-Year Results 3Boston Scientific Carotid Artery Stenting Trials Produce Positive Three-Year Results 4Boston Scientific Carotid Artery Stenting Trials Produce Positive Three-Year Results 5
Bledsoe Extender Knee Brace
Bledsoe Post-Op Knee Brace
Bledsoe Basic Knee Brace
Extensor™ Patellar Knee Support with Lateral Strap
Medicine Products: